The cross pollinization of executives between Roche and its big biotech subsidiary Genentech is continuing today with news that the South San Francisco branch of the family is reeling back one of its former execs in Basel to take the top job.
In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)
The best place to read Endpoints News? In your inbox.
Comprehensive daily news report for those who discover, develop, and market drugs. Join 47,400+ biopharma pros who read Endpoints News by email every day.Free Subscription